Which drug, and when, for patients with BRAF-mutant melanoma?
Year: 2013
Type: review
Source: The Lancet Oncology
Authors: Sekwon Jang, Michael B Atkins
Language: English
Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2116362236
